Neoprobe gets grant to further Lymphoseek development

11/3/2010 | MarketWatch

Neoprobe has received a nearly $250,000 grant from the qualifying therapeutic discovery project program, which was developed under the health reform law. "This cash award will provide additional support for the development of Lymphoseek, our lead program, without diluting the value of either our assets or our equity," President and CEO David C. Bupp said.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park